-transparent.png){kind=logo}
It is impossible to prove that any chemical, natural or man-made, cannot cause cancer in man. However, it is possible to estimate the relative degrees of risk associated with various agents. The precision of these estimations increases as experimental procedures elucidate the basic type of mechanism associated with carcinogenesis, the role of absorption, metabolism and distribution, and excretion in increasing or decreasing activity, and the dose dependency of metabolic pathways. We must constantly strive to make the most accurate risk estimations possible so that the complex issues of risk/benefit may be properly considered.
Related Publications
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
April 2012,
Deutsches Arzteblatt international,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
August 2009,
Deutsches Arzteblatt international,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
February 1978,
Environmental health perspectives,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
February 1978,
Environmental health perspectives,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
April 2009,
Environmental health perspectives,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
August 2016,
Deutsches Arzteblatt international,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
June 2003,
Archives of disease in childhood,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
August 1998,
Regulatory toxicology and pharmacology : RTP,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
December 1987,
Environmental health perspectives,
R H Reitz, and
J F Quast, and
A M Schumann, and
P G Watanabe, and
P J Gehring
January 1987,
Clinical and experimental rheumatology,
